Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novo-Nordisk A/S

61.23
-1.4008-2.24%
Volume:2.26M
Turnover:137.70M
Market Cap:271.80B
PE:19.49
High:61.47
Open:60.66
Low:60.57
Close:62.63
Loading ...

Unusually active option classes on open March 10th

TIPRANKS
·
10 Mar

Pfizer Stock Up Almost 6% in 3 Months: Time to Buy, Sell or Hold?

Zacks
·
10 Mar

5 Things to Know Before the Stock Market Opens

Investopedia
·
10 Mar

Ozempic parent's new weight-loss drug works better, but not quite good enough

Dow Jones
·
10 Mar

Novo Nordisk down 6% after results for trial of weight-loss drug CagriSema

TIPRANKS
·
10 Mar

Novo Nordisk (NVO) Stock Dips While Market Gains: Key Facts

Zacks
·
08 Mar

Novo Nordisk (0QIU) Gets a Buy from UBS

TIPRANKS
·
07 Mar

Pharma Stock Roundup: BAYRY's Q4 Results, ABBV's Obesity Deal & More

Zacks
·
07 Mar

Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup

Quartz
·
07 Mar

Sector Update: Health Care Stocks Softer Late Afternoon

MT Newswires Live
·
07 Mar

Sector Update: Health Care Stocks Retreat Thursday Afternoon

MT Newswires Live
·
07 Mar

Novo Nordisk Faces a Perfect Storm: Tariff Shock and Legal Battle Threaten Its Blockbuster Drugs

GuruFocus.com
·
07 Mar

European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading

MT Newswires Live
·
07 Mar

Novo Nordisk CEO Reportedly Flags 'Short-Term Impact' From Trump Tariffs

MT Newswires Live
·
07 Mar

Even your weight loss drugs aren't safe from tariffs

Quartz
·
06 Mar

Novo Nordisk Lowers Wegovy Costs for Cash-Pay Patients, Stock Up 4%

Zacks
·
06 Mar

Company News for Mar 6, 2025

Zacks
·
06 Mar

Wegovy Gets Cheaper! Novo Nordisk Takes on Eli Lilly as Obesity Drug Battle Heats Up

TIPRANKS
·
06 Mar

Why Novo Nordisk Stock Outpaced the Market Today and Hims & Hers Lagged It

Motley Fool
·
06 Mar

Hims & Hers’ weight loss strategy validated by Novo DTC offering, says BofA

TIPRANKS
·
06 Mar